000			03904cam a2200517 i 4500
001			19134394
003			OSt
005			20240305193121.0
008			160613t20172017ne a b 001 0 eng c
010			_a 2016944588
016	7		_a101701102 _2DNLM
020			_a9780128023020 _qpaperback
020			_a0128023023 _qpaperback
035			_a(OCoLC)ocn950449945
040			_aNLM _beng _cNLM _erda _dYDXCP _dBDX _dTKN _dOCLCF _dBTCTA _dOCLCO _dNLM _dOCLCO _dDLC
042			_apcc
050	0	0	_aQR189 _b.H862 2017
060	0	0	_a2017 B-458
060	1	0	_aQW 805
130	0		_aHuman vaccines (Modjarrad) _99986
245	1	0	_aHuman vaccines : _bemerging technologies in design and development / _cedited by Kayvon Modjarrad, MD, PhD, Associate Director, Emerging Infectious Disease Threats, Military HIV Research Program/Walter Reed Army Institute of Research, Bethesda, MD, USA, Wayne C. Koff, PhD, President and CEO, Human Vaccines Project, New York, NY, USA.
264		1	_aAmsterdam : _bElsevier/Academic Press, _c[2017]
300			_axvii, 191 pages : _billustrations (some color) ; _c23 cm
336			_atext _btxt _2rdacontent
337			_aunmediated _bn _2rdamedia
338			_avolume _bnc _2rdacarrier
504			_aIncludes bibliographical references and index.
505	0		_aPart I. Designing vaccines from a new starting point : Broadly neutralizing antibodies / L. Morris and T.A. Moody -- part II. Pathogen free vaccines : Replication-competent viral vectors for vaccines delivery / C.L. Parks ; Reverse vaccinology: exploiting genomes for vaccines design / E. Del Tordello, R. Rappuoli and I. Delany ; Virus-like particle and nanoparticle vaccines / M. Kanekiyo and C.B. Buck -- part III. Immune monitoring : Systems vaccinology / M. Rolland and M.A. Eller ; Immunogenetics and vaccination / M. John, S. Gaudieri and S. Mallal -- part IV. Advanced vaccine development : Methodical considerations / P.B. Gilbert and R. Gottardo ; Vaccine development in special populations / K.M. Edwards and C.B. Creech.
520			_a"Human Vaccines: Emerging Technologies in Design and Development discusses the advances in molecular biology, biophysics, and informatics-among other disciplines-that have provided scientists with the tools to create new vaccines against emerging and re-emerging pathogens. For example, the virus-like particle technologies that led to licensing of highly efficacious HPV vaccines have only come into full realization in the last 10 years. Their success has, in turn, accelerated the pace with which nanoparticle vaccines are being developed Given the rapidity with which the field is changing and the absence of any text documenting this change, there is a need for a resource that surveys these new vaccine technologies, assesses their potential, and describes their applications. This book provides that resource and complements traditional vaccinology books, but also serves as an excellent standalone for researchers and students with basic knowledge in immunology."-- _cProvided by publisher.
530			_aAlso issued online.
650		0	_aVaccines _xBiotechnology. _99987
650		0	_aVaccines _xDesign. _99988
650		0	_aVaccination. _99989
650	1	2	_aVaccines. _96638
650	2	2	_aDrug Discovery _xtrends. _99990
650	2	2	_aTechnology, Pharmaceutical _xtrends. _99991
650		7	_aVaccination. _2fast _0(OCoLC)fst01163544 _99989
650		7	_aVaccines _xBiotechnology. _2fast _0(OCoLC)fst01163574 _99987
650		7	_aVaccines _xDesign. _2fast _0(OCoLC)fst01163576 _99988
700	1		_aModjarrad, Kayvon, _eeditor. _99992
700	1		_aKoff, Wayne C., _eeditor. _99993
856	4		_uhttp://www.sciencedirect.com/science/book/9780128023020
906			_a7 _bcbc _cpccadap _d2 _encip _f20 _gy-gencatlg
942			_2ddc _cBK
999			_c13537 _d13537